جست‌وجوی استاد و پژوهشگر

• Sleep Biology
• Neurodevelopment
• Chronic Pain
• +۵ مورد دیگر

Professor Richelle Mychasiuk, affiliated with the School of Medical Sciences at the University of Sydney, specializes in Sleep Biology and the neurobiological impacts of early life experiences. Her research focuses on how perinatal trauma and adverse childhood events shape neurodevelopment, increasing susceptibility to sleep disturbances, chronic pain, and post-concussive symptomologies in adolescents, with a particular emphasis on sex differences. Education: PhD in Neuroscience Her work explores mechanisms by which early life stressors "under the skin" to alter neuroplasticity and microbiome-gut-brain interactions. She co-founded The GIN hub, integrating Gastroenterology, Immunology, and Neuroscience to study complex chronic disease models. Recent articles highlight her contributions to understanding dietary influences on pain, epigenetic modifications, microbiome depletion effects, and neurovascular interventions in TBI models. Grants: 2025 FMH Start-up Scheme (Faculty of Medicine and Health, University of Sydney) Collaborations: Brain and Mind Centre, University of Sydney; clinical research partnerships for translational studies.

• Neuroscience
• Metabolism
• Behavioral Neuroscience
• +۳ مورد دیگر

Dr. Paulius Viskaitis is a Researcher affiliated with the Rehabilitation Engineering Lab at ETH Zürich's Department of Health Sciences and Technology. His work focuses on the neurophysiological mechanisms underlying metabolic regulation, motor behavior, and neurological disorders. Key research areas include orexin neuron dynamics, hypothalamic circuitry, and their roles in movement, energy homeostasis, and epilepsy mitigation. His studies integrate experimental neuroscience with engineering approaches, exploring how neural networks encode metabolic states and behavioral outputs. Notable contributions include identifying orexin neurons' roles in blood glucose tracking and seizure suppression. Current research emphasizes translational applications in rehabilitation engineering and neurotherapeutic strategies. Dr. Viskaitis collaborates across disciplines, leveraging mouse models to investigate neural circuits governing feeding, locomotion, and decision-making. His findings bridge basic neuroscience with clinical applications, particularly in metabolic and motor disorders.

• Behavioral Neuroscience
• Neurobiology of Anxiety
• Synaptic Plasticity
• +۴ مورد دیگر

Professor David Bannerman is a leading academic in Behavioral Neuroscience at the University of Oxford's Department of Psychiatry. He heads the Behavioural Neuroscience Unit, focusing on neural mechanisms underlying anxiety, learning, and memory. His research integrates neurophysiological, genetic, and pharmacological approaches to study neuropsychiatric disorders such as Alzheimer’s, schizophrenia, and sleep disturbances. Education: BSc (Hons) and PhD qualifications are listed. His research interests span synaptic plasticity, neurodegenerative processes, and the neurobiology of fear/anxiety. Notable areas include the role of orexin pathways in anxiety, tau protein effects on spatial cognition, and the impact of psychedelics like 5-MeO-DMT on neural states. He also investigates sleep spindles’ role in brain state regulation and the consequences of SSRI discontinuation on serotonergic systems. Recent work emphasizes Alzheimer’s disease mechanisms (e.g., amyloid β’s synaptic effects), schizophrenia models (NMDA receptor dysfunction), and the neuroplasticity linked to working memory training. His lab employs cutting-edge techniques, including optogenetics and in vivo neural recordings, to dissect complex behaviors and circuit-level dysfunction. His publications highlight interdisciplinary approaches, bridging basic neuroscience with translational research. Key themes include: synaptic dysfunction in neurodegeneration, environmental influences on neurobehavioral outcomes (e.g., magnetic fields), and the neurobiological basis of psychiatric symptomatology.

• Neuropharmacology
• Metabolic Disease Research
• Neuroendocrinology
• +۵ مورد دیگر

Paula Goforth is an Assistant Professor at the University of Michigan Medical School , affiliated with the Department of Pharmacology and the Caswell Diabetes Institute . Her research focuses on the intersection of neuropharmacology and metabolic disease, particularly leptin signaling, orexin regulation, and hypothalamic circuits controlling glucose homeostasis and energy balance. Education: Postdoctoral training at Virginia Commonwealth University School of Medicine (2000-2004), specializing in Pharmacology under Dr. Satin LS. Her work explores neuron-specific metabolic regulation , including calcium channel modulation in obesity, orexin-glucose axis dynamics, and GABA-independent hypothalamic signaling. She employs techniques such as cell-type-specific circuit dissection and synaptic physiology to study these mechanisms. Recent publications highlight her expertise in leptin-regulated pathways , area postrema neuron function , and traumatic brain injury-related receptor changes , with implications for diabetes, obesity, and neurodegenerative diseases. Scientific Awards: NIH grants spanning 2013-2029, including dual awards for leptin action and gut-brain axis research Industry collaborations with Eli Lilly, Pfizer, and MedImmune LLC University of Michigan institutional support for diabetes/metabolic research Dr. Goforth's laboratory investigates metabolically coupled ion channels and neuronal population dynamics in metabolic disease models, with a strong emphasis on translational neuroscience applications.

Emmanuel Pothosمشاهده پروفایل

دانشیار

• Neuroscience
• Neurochemistry
• Molecular Biology
• +۷ مورد دیگر

Emmanuel Pothos is an Associate Professor at Tufts University School of Medicine in the Department of Immunology. His research explores the cellular and molecular mechanisms of synaptic neurotransmission in the midbrain and its catecholaminergic projections, with a focus on neurochemistry and molecular biology of disorders like obesity, drug addiction, psychotic disorders, and Parkinson’s disease. He leads a lab studying the plasticity of CNS catecholamine quantal size and its pharmacological intervention potential. Doctor of Philosophy, Princeton University, 1994 Master of Arts, Princeton University, 1990 Bachelor of Arts, University of Athens, 1988 His publications span neuroscience, neuroendocrinology, and translational medicine, addressing topics such as insulin signaling in astrocytes, dopamine turnover in obesity, and genetic models of dyskinesia. He has secured significant grants from NIH, Pfizer, and other foundations to investigate preclinical interventions for obesity, addiction, and neurodegenerative diseases. Astrocyte-derived signals and mental illness (NIH, 2021–2026) Intranasal delivery of GDNF for opioid relapse prevention (CTSI, 2020–2022) MCH antibody therapy for IBD (Pfizer, 2018–2019) He teaches courses in Addiction Medicine, Translational Pharmacology, and Graduate Research at Tufts, and has presented at conferences including the Society for Neuroscience Annual Meeting and Tufts Talks Obesity Seminar Series. His work bridges neurobiology, metabolic disorders, and public health policy.

William Howeمشاهده پروفایل

استادیار

• Neuroscience
• Neurobiology of Behavior
• Neuropsychiatric Disorders
• +۳ مورد دیگر

William Howe is an Assistant Professor at the School of Neuroscience, Virginia Tech, where he joined in Fall 2019. He earned his Ph.D. in Neuroscience from the University of Michigan under Martin Sarter, followed by industry experience at Pfizer and postdoctoral training at the Icahn School of Medicine at Mt. Sinai with Paul Kenny. Education : Ph.D. University of Michigan His research focuses on neurobiological mechanisms underlying reward learning, motivation, and executive control, particularly how dysregulation in orexin, cholinergic, and dopaminergic systems contributes to neuropsychiatric and neurodegenerative disorders. His lab employs multidisciplinary methods, including optogenetics, viral gene manipulation, and optical neural activity measurement. Recent publications highlight his work on nicotine addiction, depression, and attention resilience, with trends spanning cholinergic signaling, striatal networks, and gene-editing applications. Key journals include Nature , Nature Neuroscience , and Current Biology .

• Neurobiology
• Theoretical and Computational Neurobiophysics
• Neurodevelopment
• +۵ مورد دیگر

Pınar ÖZ is an Associate Professor at Uskudar University, Department of Molecular Biology and Genetics, since 2015. Her research spans neurobiology, computational neuroscience, and neurodevelopmental disorders, with a focus on membrane properties, adult neurogenesis, and orexin system dynamics. Boğaziçi University, Institute of Biomedical Engineering (2012–2014) Max Planck Institute for Dynamics and Self-organization (2011–2012) Research Interests: Computational modeling of neuronal excitability Neurodevelopmental disorders, including autism models Role of orexin in sleep deprivation and sensorimotor gating Neuroprotective agents (e.g., zeatin) in ischemic models Evolutionary bioinformatics of neurochemical pathways Applications of agent-based modeling in neurogenesis Recent Trends: Publications from 2015–2025 emphasize interdisciplinary approaches combining in vitro and in vivo models with computational tools to study hippocampal plasticity, neurodegeneration, and pharmacological interventions. Scientific Awards: Georg Christoph Lichtenberg Scholarship (Lower Saxony Ministry of Science and Culture, Germany, 2008–2009) Projects: Investigates personalized drug monitoring, neuroprotective effects of zeatin, orexin system's role in psychosis models, and computational frameworks for neurogenesis. She also supervises graduate theses on topics like neurodevelopmental inhibition networks and age-dependent simulations.

Stephanie Borglandمشاهده پروفایل

استاد

• Neuroscience
• Neurobiology of reward and addiction
• Synaptic plasticity
• +۴ مورد دیگر

Stephanie Borgland is a Professor at the University of Calgary and a member of the Hotchkiss Brain Institute . Her research integrates cellular physiology , pharmacology , and behavioral neuroscience to explore the neurobiological underpinnings of addiction , obesity , and motivational disorders . She leads a laboratory that uses brain slice electrophysiology , optogenetics , and immunohistochemistry to study synaptic plasticity and neuropeptide signaling in dopaminergic circuits. Research Interests: Neuropeptide modulation of synaptic plasticity in reward circuits Dopamine signaling in the ventral tegmental area (VTA) Obesity and compulsive eating behavior Drug addiction and reward processing Neuroadaptations following chronic drug exposure Her recent work has focused on how cannabis exposure during development affects metabolism and behavior, how orexin and dynorphin modulate dopamine neurons, and how diet-induced obesity alters decision-making and reward circuits. Her studies span from molecular mechanisms to behavioral outcomes, often incorporating sex differences and developmental perspectives . Contact & Support: Email: s.borgland@ucalgary.ca Office: HSC2107, University of Calgary Phone: 403-220-6967 Administrative Assistant: Dolma Dejikhangsar ( dolma.dejikhangsar@ucalgary.ca ) She maintains an active publication record with over 100 peer-reviewed articles indexed in PubMed and Google Scholar, reflecting her leadership in translational neuroscience research.

Sigrid C. Veaseyمشاهده پروفایل

استاد

• Sleep Disorders
• Neuroscience
• Neurodegeneration
• +۵ مورد دیگر

Sigrid C. Veasey is a Professor of Medicine (Sleep Medicine) at the Perelman School of Medicine, University of Pennsylvania , affiliated with the Department of Medicine and the Division of Sleep Medicine. As an attending physician at the Hospital of the University of Pennsylvania, she combines clinical practice with translational research on sleep disorders. B.S. in Biochemistry (Sweet Briar College, 1981) M.D. (University of Virginia, 1985) Research Focus : Dr. Veasey's lab investigates the molecular mechanisms of neural injury in sleep disorders, particularly chronic sleep loss and sleep fragmentation . Key discoveries include SIRT1 regulation of wake-active neurons, amyloid-β accumulation , and tau degeneration in Alzheimer's disease models. Current work explores neuroinflammatory pathways and synaptic pruning in the locus coeruleus. Article Trends : Her recent publications span neuroscience and sleep medicine , focusing on sleep-neurodegeneration links , opioid interactions , and circadian rhythm effects . Subfields include amyloid cascades , neuroinflammation , and animal models of sleep injury.

Gorica Petrovichمشاهده پروفایل

استاد

• Neurobiology of motivation
• Feeding behavior
• Neural circuitry
• +۵ مورد دیگر

Gorica Petrovich is a Professor in the Department of Psychology at Boston College, with joint affiliation in Neuroscience. She holds a Ph.D. from the University of Southern California and directs the Neurobiology of Feeding Behavior Laboratory. Her research examines cognitive and hedonic control of food motivation using multidisciplinary approaches. Research Focus: Dr. Petrovich investigates neural mechanisms underlying feeding behavior, including: Modulation of hunger/satiety by learning and stress Sex and age differences in motivational systems Neural plasticity in cognitive control circuits Forebrain-hypothalamic connectivity Her work combines behavioral neuroscience, systems neuroanatomy, and learning theory. Publication Trends: Recent articles demonstrate consistent focus on sex-specific neural circuitry in feeding behavior, with emerging emphasis on thalamic regulation and cross-species validation of motivational mechanisms. Laboratory: Leads the Neurobiology of Feeding Behavior Laboratory, utilizing electrophysiological, pharmacological, and behavioral techniques to study adaptive control of feeding.

• Behavioural neuroscience
• Alcohol use disorder
• Neural circuitry
• +۴ مورد دیگر

Dr. Erin Campbell is a behavioral neuroscientist at the University of Newcastle , currently holding a DECRA Fellowship within the School of Biomedical Sciences and Pharmacy . With a career spanning multiple prestigious institutions including the Florey Institute of Neuroscience and Mental Health and University of Melbourne , her research focuses on the neural mechanisms underlying alcohol use disorder and stress-related relapse . Her work employs advanced techniques like optogenetics , chemogenetics , and neural tracing to map brain circuits involved in addiction and compulsive behaviors. PhD in Anatomy from University of Newcastle BPsych (Hons) from University of Newcastle Dr. Campbell's research investigates alcohol-seeking relapse mechanisms , stress-induced binge eating , and orexin system functionality . Her work spans neural circuit mapping, neurotransmitter analysis, and translational studies with clinical implications. She's particularly interested in context-induced relapse , sex differences in addiction , and environmental enrichment effects on recovery. Her publication record shows a strong focus on insular cortex , nucleus accumbens shell , and lateral hypothalamus research. Key themes include glutamatergic projections , opioid receptor antagonists , and serotonin receptor targets . Her recent grant funding includes NARSAD Young Investigator Grants and DECRA Fellowship for AUD research. 2025: $107,931 NARSAD grant for serotonin-targeted AUD treatments 2022: $437,403 ARC Discovery Early Career Researcher Award 2019: $772,521 NHMRC project grant 2018: $100,000 Perpetual Limited grant for suvorexant AUD research Dr. Campbell actively supervises 8 completed and 4 ongoing research projects , mentoring students in behavioral neuroscience , stress-related compulsivity , and reward-seeking mechanisms . Her teaching experience includes guest lectures at Victoria University and University of Melbourne on neuroscience of behavior and clinical genetics .

• Neuroscience
• Neuropharmacology
• Parkinson's Disease Research
• +۳ مورد دیگر

Jack W. Lipton is a Professor and Chair of Translational Science and Molecular Medicine at Michigan State University (MSU) College of Human Medicine. He holds concurrent appointments as Teaching Faculty in MSU's Neuroscience Program and Associate Dean for Research Analytics. His career spans leadership roles at Rush University Medical Center and University of Cincinnati before joining MSU in 2009. B.A. in Psychology, UC Berkeley (1988) Ph.D. in Behavioral Neuroscience, UCLA (1993) Postdoctoral Fellowship, Rush Children's Hospital Dr. Lipton's research focuses on developmental neurotoxicology and translational Parkinson's disease models . His work examines gestational drug exposure effects, including MDMA-induced dopamine neuron sprouting, and develops therapeutic strategies like neural transplantation, gene therapy, and deep brain stimulation. Current projects investigate alpha-synuclein pathology, Nurr1 gene regulation, and saliva-based SARS-CoV-2 testing protocols. Prominent scientific achievements include continuous NIH funding since 1993, the Morris K. Udall Center of Excellence in Parkinson's Research, and over 50 publications. His lab's 2025 study on alpha-synuclein fibrils and 2022 saliva testing framework demonstrate methodological innovation. Scientific Awards: NIH/NIDA R01 grants NIH/NINDS funding Michael J. Fox Foundation awards Morris K. Udall Center leadership 2024 NIH grant for saliva diagnostics Dr. Lipton's technical expertise spans neuronal culture, ELISA, mass spectrometry, PCR arrays, and stereotaxic surgery. His lab collaborates with Drs. Timothy Collier, Caryl Sortwell, and Kathy Steece-Collier on Parkinson's disease mechanisms. Recent initiatives include federal regulatory advocacy for university-based pandemic testing and op-eds in Wall Street Journal and Washington Post .

Gina Leinningerمشاهده پروفایل

استاد

• Neuroscience
• Neurophysiology
• Physiology
• +۴ مورد دیگر

Gina Leinninger is a Red Cedar Distinguished Professor at the Department of Physiology, Michigan State University, and holds affiliations with the Neuroscience Program and Genetics & Genome Sciences Program. She serves as Graduate Director of the Molecular, Cellular, and Integrative Physiology Graduate Program at the BioMolecular Science Gateway. Research Focus: Neurophysiological mechanisms of lateral hypothalamic area (LHA) neurons in energy balance regulation Key Techniques: Novel mouse models, neuronal tract tracing, and neuroregulation technologies Her research investigates how LHA neuronal populations (neurotensin, orexin, leptin receptor-expressing) respond to metabolic stimuli like adiposity signals, dehydration, and exercise, and how they modulate dopamine circuits to influence hedonic feeding, locomotion, and weight regulation. Current work explores therapeutic potential of LHA signaling for obesity and metabolic disorders. Recent publications reveal trends in Neurotensin-dopamine interaction Sex-dependent neural circuits Metabolic stimulus response mapping Neuronal projection analysis High-fat diet behavioral models Neurobiological basis of comorbid obesity-pain Her lab's work connects LHA dysfunction to pathogenesis of obesity through advanced methodologies in neuronal regulation and metabolic signaling.

• Sleep Medicine
• Neurology
• Neurodegenerative Disorders
• +۵ مورد دیگر

Liborio Parrino is a Full Professor of Neurology at the University of Parma's Department of Medicine and Surgery. He is the Director of the Sleep Medicine Center and the School of Specialization in Neurology at the University of Parma. His roles include coordinating multidisciplinary diagnostic-therapeutic pathways for sleep disorders and serving as President of the Italian Association of Sleep Medicine (AIMS) since 2012. Parrino holds a PhD in Neurological and Neurosensory Disciplines and has extensive international collaborations, including contributions to the International Classification of Sleep Disorders (ICSD-2) and leadership in the World Association of Sleep Medicine (WASM). Education: MD in Medicine and Surgery, University of Padua (1980) Specialization in Neurology, University of Parma (1985) PhD in Neurological and Neurosensory Disciplines His research focuses on sleep disorders, neurodegeneration, and sleep microstructure. He has authored over 156 ISI-indexed publications (H-index: 35) and reviews manuscripts for journals like SLEEP and CLINICAL NEUROPHYSIOLOGY . Parrino is a founding member of WASM, chairs multiple international committees, and has organized major sleep medicine conferences, including the 2012 AIMS Congress in Parma. Teaching responsibilities include courses in Neurology, Sleep Medicine, and Audiometry. He advises on clinical protocols for regional health authorities and collaborates with organizations like Medlink Neurology. His work bridges clinical practice, research, and global advocacy for sleep medicine.

• Psychiatry
• Depression Research
• Neuroimmunology
• +۵ مورد دیگر

Dr. Jennifer Lynn Kruse is an HS Associate Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). Her research focuses on the intersection of psychiatry, neuroscience, and immunology, with particular emphasis on treatment-resistant depression and the role of inflammation in mental health. Dr. Kruse's primary research interests include: Electroconvulsive therapy (ECT) mechanisms and outcomes Neuroimmunology of depression Sex differences in depression treatment response Role of cytokines (particularly Interleukin-8) in mood disorders Psychiatric manifestations of autoimmune conditions Novel treatments for treatment-resistant depression Analysis of Dr. Kruse's recent publications reveals a strong focus on the relationship between inflammation and depression treatment response. Her work frequently examines how inflammatory markers, particularly Interleukin-8, correlate with treatment outcomes in depression. A notable trend is her investigation of sex-specific differences in treatment response, with several publications highlighting how inflammatory mechanisms may differ between males and females with depression. Her research spans multiple treatment modalities including electroconvulsive therapy, ketamine, and inflammatory challenge paradigms, consistently connecting immune system activity with psychiatric symptomatology. Dr. Kruse served as Principal Investigator on the NIH-funded project "Depression Response to Fast-Acting Treatments: Inflammation and Reward Mechanisms" (K23MH116127) from September 2018 to August 2022. This research grant investigated the biological mechanisms underlying rapid-acting antidepressant treatments, with a specific focus on inflammatory processes and neural reward circuitry. Her collaborative network includes prominent researchers at UCLA such as Dr. Michael Irwin (a leading expert in psychoneuroimmunology), Dr. John Brooks, and Dr. Katherine Narr. These collaborations have resulted in numerous high-impact publications examining the neurobiological underpinnings of depression treatment response.